Logo image of MRM

MEDIROM HEALTHCARE TECHNOLOG (MRM) Stock Fundamental Analysis

USA - NASDAQ:MRM - US58510H1032 - ADR

1.77 USD
+0.01 (+0.57%)
Last: 9/22/2025, 8:47:04 PM
1.77 USD
0 (0%)
After Hours: 9/22/2025, 8:47:04 PM
Fundamental Rating

2

MRM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of MRM have multiple concerns. MRM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MRM had negative earnings in the past year.
In the past year MRM has reported a negative cash flow from operations.
In multiple years MRM reported negative net income over the last 5 years.
In the past 5 years MRM always reported negative operating cash flow.
MRM Yearly Net Income VS EBIT VS OCF VS FCFMRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

MRM has a Return On Assets (1.84%) which is in line with its industry peers.
MRM's Return On Equity of 15.94% is fine compared to the rest of the industry. MRM outperforms 80.00% of its industry peers.
With a Return On Invested Capital value of 0.09%, MRM perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
ROA 1.84%
ROE 15.94%
ROIC 0.09%
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRM Yearly ROA, ROE, ROICMRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

MRM has a Profit Margin (1.79%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MRM has grown nicely.
MRM has a Operating Margin (0.06%) which is in line with its industry peers.
MRM's Operating Margin has declined in the last couple of years.
The Gross Margin of MRM (27.07%) is worse than 68.00% of its industry peers.
MRM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.06%
PM (TTM) 1.79%
GM 27.07%
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
MRM Yearly Profit, Operating, Gross MarginsMRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

MRM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MRM has been increased compared to 1 year ago.
Compared to 5 years ago, MRM has more shares outstanding
Compared to 1 year ago, MRM has a worse debt to assets ratio.
MRM Yearly Shares OutstandingMRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MRM Yearly Total Debt VS Total AssetsMRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that MRM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.02, MRM perfoms like the industry average, outperforming 50.67% of the companies in the same industry.
A Debt/Equity ratio of 1.35 is on the high side and indicates that MRM has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.35, MRM is doing worse than 65.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACC0.04
WACC2.28%
MRM Yearly LT Debt VS Equity VS FCFMRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

2.3 Liquidity

MRM has a Current Ratio of 0.65. This is a bad value and indicates that MRM is not financially healthy enough and could expect problems in meeting its short term obligations.
MRM has a worse Current ratio (0.65) than 74.67% of its industry peers.
A Quick Ratio of 0.61 indicates that MRM may have some problems paying its short term obligations.
MRM has a Quick ratio of 0.61. This is in the lower half of the industry: MRM underperforms 74.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.61
MRM Yearly Current Assets VS Current LiabilitesMRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

MRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.69%.
MRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.92% yearly.
MRM shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.55%.
MRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.25% yearly.
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRM Yearly Revenue VS EstimatesMRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRM Price Earnings VS Forward Price EarningsMRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MRM is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.71
MRM Per share dataMRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDIROM HEALTHCARE TECHNOLOG

NASDAQ:MRM (9/22/2025, 8:47:04 PM)

After market: 1.77 0 (0%)

1.77

+0.01 (+0.57%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-20 2025-05-20
Earnings (Next)N/A N/A
Inst Owners4.05%
Inst Owner Change-59.55%
Ins Owners25.57%
Ins Owner ChangeN/A
Market Cap13.99M
Analysts0
Price TargetN/A
Short Float %8.53%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 2.22
P/tB N/A
EV/EBITDA 11.71
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.62
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS7.1
BVpS0.8
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 15.94%
ROCE 0.12%
ROIC 0.09%
ROICexc 0.09%
ROICexgc 0.13%
OM 0.06%
PM (TTM) 1.79%
GM 27.07%
FCFM N/A
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-46.9%
ROICexc growth 3YN/A
ROICexc growth 5Y-50.51%
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 4.26
Cap/Depr 194.74%
Cap/Sales 6.81%
Interest Coverage 0.1
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.61
Altman-Z 1.02
F-Score6
WACC2.28%
ROIC/WACC0.04
Cap/Depr(3y)216.74%
Cap/Depr(5y)157.89%
Cap/Sales(3y)7.57%
Cap/Sales(5y)5.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y101.04%
EBIT growth 3YN/A
EBIT growth 5Y-42.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.8%
OCF growth 3YN/A
OCF growth 5YN/A